Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.

	Jun '14	Jun '15	Jun '16	Jun '17	Jun '18	Jun '19	Jun '20	Jun '21	Jun '22	Jun '23
revenue	691.90M -	748.59M 8.19%	751.50M 0.39%	764.30M 1.70%	820M 7.29%	828M 0.98%	800.40M 3.33%	833.40M 4.12%	942.30M 13.07%	977.89M 3.78%
cost of revenue	484.10M -	512.22M 5.81%	512.50M 0.05%	516M 0.68%	553.10M 7.19%	563.40M 1.86%	543.50M 3.53%	562M 3.40%	656.90M 16.89%	679.65M 3.46%
gross profit	207.80M -	236.37M 13.75%	239M 1.11%	248.30M 3.89%	266.90M 7.49%	264.60M 0.86%	256.90M 2.91%	271.40M 5.64%	285.40M 5.16%	298.24M 4.50%
selling and marketing expenses
general and administrative expenses
selling general and administrative expenses	144M -	148.70M 3.27%	153.30M 3.09%	150.30M 1.96%	168M 11.78%	181.40M 7.98%	187.70M 3.47%	196.50M 4.69%	206.40M 5.04%	226.39M 9.69%
research and development expenses						12.08M -	13.74M 13.70%	17.76M 29.27%	20.83M 17.30%	24.39M 17.10%
other expenses
cost and expenses	628.10M -	660.92M 5.23%	665.80M 0.74%	666.30M 0.08%	721.10M 8.22%	744.80M 3.29%	731.20M 1.83%	758.50M 3.73%	863.30M 13.82%	906.04M 4.95%
operating expenses	144M -	148.70M 3.27%	153.30M 3.09%	150.30M 1.96%	168M 11.78%	181.40M 7.98%	187.70M 3.47%	196.50M 4.69%	206.40M 5.04%	226.39M 9.69%
interest expense	33M -	14.55M 55.90%	16.60M 14.06%	14.90M 10.24%	11.90M 20.13%	11.80M 0.84%	12.90M 9.32%	12.90M 0%	11.90M 7.75%	17.95M 50.83%
ebitda	63.90M -	109.52M 71.39%	85.80M 21.66%	97.90M 14.10%	98.90M 1.02%	83.40M 15.67%	69.20M 17.03%	74.90M 8.24%	79M 5.47%	108.49M 37.33%
operating income	63.80M -	87.67M 37.41%	85.70M 2.24%	97.90M 14.24%	98.90M 1.02%	73.30M 25.88%	36.86M 49.72%	43.02M 16.70%	46.30M 7.63%	71.85M 55.19%
depreciation and amortization	21.45M -	21.60M 0.70%	23.45M 8.55%	26.00M 10.87%	26.94M 3.62%	27.56M 2.30%	32.34M 17.33%	31.89M 1.41%	32.70M 2.57%	34.01M 4.00%
total other income expenses net	-24.60M -	5.40M 121.95%	7.60M 40.74%	-2.50M 132.89%	1.10M 144%	15.66M 1,324%	18.64M 19.01%	23.48M 25.99%	26.00M 10.73%	-2.46M 109.44%
income before tax	6.30M -	78.76M 1,150.21%	76.80M 2.49%	80.50M 4.82%	88.10M 9.44%	71.50M 18.84%	55.50M 22.38%	66.50M 19.82%	72.30M 8.72%	54.07M 25.21%
income tax expense	9.40M -	18.48M 96.63%	-6M 132.46%	15.90M 365%	23.20M 45.91%	16.80M 27.59%	22M 30.95%	12.10M 45%	23.20M 91.74%	21.46M 7.48%
net income	-3.10M -	60.28M 2,044.52%	82.70M 37.19%	64.60M 21.89%	64.90M 0.46%	54.70M 15.72%	33.55M 38.66%	54.38M 62.09%	49.17M 9.58%	32.61M 33.69%
weighted average shs out	31.27M -	38.97M 24.62%	39.30M 0.85%	39.50M 0.51%	40.20M 1.77%	40.41M 0.53%	40.45M 0.10%	40.47M 0.05%	40.50M 0.08%	40.50M 0%
weighted average shs out dil	32.20M -	39.81M 23.65%	40M 0.46%	40M 0%	40.40M 1%	40.52M 0.30%	40.50M 0.05%	40.50M 0%	40.50M 0%	40.50M 0%
eps	-0.10 -	1.55 1,709.55%	2.11 36.13%	1.63 22.75%	1.61 1.23%	1.35 16.15%	0.83 38.52%	1.34 61.45%	1.21 9.70%	0.81 33.06%
epsdiluted	-0.10 -	1.51 1,668.02%	2.07 37.09%	1.61 22.22%	1.61 0%	1.35 16.15%	0.83 38.52%	1.34 61.45%	1.21 9.70%	0.81 33.06%

NASDAQ:PAHC

Phibro Animal Health Corporation

Last Close

18.83

26/07 20:00

Market Cap

663.85M

Beta: 0.62

Volume Today

105.08K

Avg: 102.35K

PE Ratio

21.03

PFCF: 105.86

Dividend Yield

4.47%

Payout:93.89%

Preview